Journal of Leukemia
Open Access
ISSN: 2329-6917
+44 1300 500008
ISSN: 2329-6917
+44 1300 500008
Department of Immunotherapy, University of Nanjing, Nanjing, China
Commentary
Role of Minimal Residual Disease in Cancer Management Advances and its Challenges
Author(s): Jingyao Ren*
DOI:
10.35248/2329-6917-24.12.394